CIK 0000873303
- Large accelerated filer
Sarepta Therapeutics, Inc.
Sign in to watch- Ticker
- SRPT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 930797222
- Phone
- +1 617-274-4000
- Business address
- 215 FIRST STREET, SUITE 415, CAMBRIDGE, MA, 02142
- Former names
- Sarepta Therapeutics, Inc., AVI BIOPHARMA INC, ANTIVIRALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-07-16 | Howton David T SVP, General Counsel | Exercise or conversion | +3,096 | $13.71 | $42K | 37,967 |
| 2018-07-16 | Howton David T SVP, General Counsel | Sale | −3,096 | $136.46 | $422K | 34,871 |
| 2018-07-16 | Howton David T SVP, General Counsel | Exercise or conversion | +9,056 | $13.71 | $124K | 43,927 |
| 2018-07-16 | Howton David T SVP, General Counsel | Sale | −9,056 | $136.46 | $1.2M | 34,871 |
| 2018-07-16 | Howton David T SVP, General Counsel | Exercise or conversion | +37,848 | $13.90 | $526K | 72,719 |
| 2018-07-16 | Howton David T SVP, General Counsel | Sale | −37,848 | $136.46 | $5.2M | 34,871 |
| 2018-07-16 | Howton David T SVP, General Counsel | Exercise or conversion · Stock option (right to buy) | −3,096 | $13.71 | $42K | 7,431 |
| 2018-07-16 | Howton David T SVP, General Counsel | Exercise or conversion · Stock option (right to buy) | −9,056 | $13.71 | $124K | 10,090 |
| 2018-07-16 | Howton David T SVP, General Counsel | Exercise or conversion · Stock option (right to buy) | −37,848 | $13.90 | $526K | 27,159 |
| 2018-07-09 | Cumbo Alexander SVP, Chief Commercial Officer | Exercise or conversion | +11,924 | $13.71 | $163K | 40,690 |
| 2018-07-09 | Cumbo Alexander SVP, Chief Commercial Officer | Sale | −11,924 | $137.32 | $1.6M | 28,766 |
| 2018-07-09 | Cumbo Alexander SVP, Chief Commercial Officer | Exercise or conversion | +9,944 | $13.71 | $136K | 38,710 |
| 2018-07-09 | Cumbo Alexander SVP, Chief Commercial Officer | Sale | −9,944 | $137.32 | $1.4M | 28,766 |
| 2018-07-09 | Cumbo Alexander SVP, Chief Commercial Officer | Exercise or conversion | +11,914 | $13.90 | $166K | 40,680 |
| 2018-07-09 | Cumbo Alexander SVP, Chief Commercial Officer | Sale | −11,914 | $137.32 | $1.6M | 28,766 |
| 2018-07-09 | Cumbo Alexander SVP, Chief Commercial Officer | Exercise or conversion · Stock option (right to buy) | −11,924 | $13.71 | $163K | 3,850 |
| 2018-07-09 | Cumbo Alexander SVP, Chief Commercial Officer | Exercise or conversion · Stock option (right to buy) | −9,944 | $13.71 | $136K | 3,895 |
| 2018-07-09 | Cumbo Alexander SVP, Chief Commercial Officer | Exercise or conversion · Stock option (right to buy) | −11,914 | $13.90 | $166K | 2,250 |
| 2018-06-27 | Barry Richard Director | Sale | −75,000 | $130.34 | $9.8M | 3,170,432 |
| 2018-06-26 | INGRAM DOUGLAS S President & CEO | Shares withheld for taxes | −36,946 | $135.53 | $5.0M | 383,250 |
Page 34 of 38 · 760 trades